Derek L Chappell

Statistics

Publications

Citations

466

H-Index

Active since

2004

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Oxford

Derek L Chappell is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, mass spectrometric analysis, and peptide analysis.

Publications per year

2004–2016

Publications

Cerebrospinal Fluid Biomarkers Distinguish Postmortem-Confirmed Alzheimer's Disease from Other Dementias and Healthy Controls in the OPTIMA Cohort

Jeffrey L. Seeburger, Daniel Holder, Marc Combrinck et al. · Journal of Alzheimer s Disease · 2015 · 99 citations

Life Sciences, Neurology, Neuroscience +17

High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid

Ronald C. Hendrickson, Anita Y. H. Lee, Qinghua Song et al. · PLoS ONE · 2015 · 72 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance Test

Anita Y. H. Lee, Derek L Chappell, Monika Bąk et al. · Clinical Chemistry · 2015 · 60 citations · Full text

Life Sciences, Biochemistry, Endocrinology +13

Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients

Omar Laterza, Scott J. Cameron, Derek L Chappell et al. · Clinica Chimica Acta · 2004 · 53 citations

Medicine, Cardiology, Obstetrics +16

Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX‐2 Versus COX‐1 in Healthy Subjects

Jules I. Schwartz, Aimée Dallob, Patrick Larson et al. · The Journal of Clinical Pharmacology · 2008 · 46 citations

Medicine, Pharmacology, Pharmacotherapy +12

1–5 of 10